Skip to main content

Features

May 31, 2016

Shifting Gears

After a production volume recovery in 2015, what’s next?

May 12, 2016

Time to Unwind

New regulations regarding international taxation of multinationals will impact the attractiveness of countries for biopharma FDI.

May 5, 2016

2016 Top Deals

The Top Deals all amount to one thing: opportunities for growth — in innovation, market share, regional GDP and, in many cases, human as well as profit potential.